Separation Agreements in the Biotechnology Industry

830 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (1 contract)
ABEONA THERAPEUTICS INC. (2)
ACCELERON PHARMA INC (1)
Achaogen, Inc. (2)
ACHIEVE LIFE SCIENCES, INC. (2)
Acorda Therapeutics (1)
Actinium Pharmaceuticals, Inc. (2)
Adagio Therapeutics, Inc. (3)
Adamas Pharmaceuticals Inc (1)
ADiTx Therapeutics, Inc. (3)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (5)
Advaxis, Inc. (3)
Adverum Biotechnologies, Inc. (11)
Aerovate Therapeutics, Inc. (1)
AGENUS INC (1)
AgeX Therapeutics, Inc. (2)
AGIOS PHARMACEUTICALS INC (1)
AILERON THERAPEUTICS INC (2)
Aimmune Therapeutics, Inc. (3)
AKCEA THERAPEUTICS, INC. (5)
Akebia Therapeutics, Inc. (4)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (2)
Alector, Inc. (1)
Alexion Pharmaceuticals (3)
Aligos Therapeutics, Inc. (1)
Alkermes plc. (2)
Allakos Inc. (2)
Allarity Therapeutics, Inc. (2)
Alliqua BioMedical, Inc. (3)
Allovir, Inc. (1)
Alpha Healthcare Acquisition Corp. (1)
ALPINE IMMUNE SCIENCES, INC. (4)
Altimmune, Inc. (4)
ALX ONCOLOGY HOLDINGS INC (1)
AMARIN CORP PLC (3)
AMICUS THERAPEUTICS, INC. (1)
AmpliPhi Biosciences Corp (5)
Amplitude Healthcare Acquisition Corp (1)
ANAPTYSBIO INC (1)
Anika Therapeutics (2)
Annovis Bio, Inc. (2)
Applied Molecular Transport Inc. (3)
Applied Therapeutics Inc. (2)
Aprea Therapeutics, Inc. (4)
Aptevo Therapeutics Inc. (1)
AQUINOX PHARMACEUTICALS, INC (5)
Aravive, Inc. (8)
Arbutus Biopharma Corp (3)
ARCA biopharma, Inc. (1)
Arcus Biosciences, Inc. (1)
ARDELYX, INC. (4)
ARENA PHARMACEUTICALS INC (1)
Artiva Biotherapeutics, Inc. (1)
ARYA Sciences Acquisition Corp II (1)
ASSEMBLY BIOSCIENCES, INC. (2)
Atara Biotherapeutics, Inc. (1)
ATHERSYS, INC (1)
ATOSSA GENETICS INC (1)
aTYR PHARMA INC (2)
Aurinia Pharmaceuticals Inc. (4)
AVEO PHARMACEUTICALS INC (3)
Avid Bioservices, Inc. (1)
Avita Therapeutics, Inc. (1)
AVROBIO, Inc. (4)
Axcella Health Inc. (2)
Axovant Sciences Ltd. (5)
AZIYO BIOLOGICS, INC. (1)
BeiGene, Ltd. (2)
BELLICUM PHARMACEUTICALS, INC (2)
BIOCRYST PHARMACEUTICALS INC (1)
Biogen Inc. (2)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BIOMARIN PHARMACEUTICAL INC (2)
Biomea Fusion, Inc. (1)
BIOSPECIFICS TECHNOLOGIES CORP (2)
Biostage, Inc. (4)
BIOTIME INC (3)
BioXcel Therapeutics, Inc. (6)
Black Diamond Therapeutics, Inc. (2)
Blue Water Vaccines Inc. (1)
bluebird bio, Inc. (3)
BRAINSTORM CELL THERAPEUTICS INC. (3)
CALADRIUS BIOSCIENCES, INC. (1)
Calyxt, Inc. (5)
CANCER GENETICS, INC (1)
CAPRICOR THERAPEUTICS, INC. (2)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (1)
Capstone Therapeutics Corp. (1)
CareDx, Inc. (4)
Caribou Biosciences, Inc. (1)
CASI Pharmaceuticals, Inc. (1)
CASTLE BIOSCIENCES INC (2)
Castle Creek Biosciences, Inc. (1)
CATALYST BIOSCIENCES, INC. (5)
CATALYST PHARMACEUTICALS, INC. (2)
Celldex Therapeutics, Inc. (1)
Celsion CORP (4)
Century Therapeutics, Inc. (2)
Checkmate Pharmaceuticals, Inc. (1)
Coherus BioSciences, Inc. (1)
Comera Life Sciences Holdings, Inc. (1)
COMPASS Pathways plc (1)
Consonance-HFW Acquisition Corp. (1)
Constellation Alpha Capital Corp. (2)
CONTRAFECT Corp (3)
Corbus Pharmaceuticals Holdings, Inc. (3)
Cortexyme, Inc. (6)
Crinetics Pharmaceuticals, Inc. (1)
CTI BIOPHARMA CORP (3)
Cullinan Oncology, LLC (1)
CURIS INC (1)
Cyclacel Pharmaceuticals, Inc. (2)
Cyclerion Therapeutics, Inc. (3)
CytoDyn Inc. (4)
CytomX Therapeutics, Inc. (8)
CYTORI THERAPEUTICS, INC. (1)
CYTRX CORP (1)
DBV Technologies S.A. (1)
DelMar Pharmaceuticals, Inc. (1)
Dermavant Sciences Ltd (1)
Design Therapeutics, Inc. (1)
DiaMedica Therapeutics Inc. (2)
Dicerna Pharmaceuticals Inc (1)
Diffusion Pharmaceuticals Inc. (10)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (4)
Edge Therapeutics, Inc. (1)
Editas Medicine, Inc. (3)
Eiger BioPharmaceuticals, Inc. (12)
Elevation Oncology, Inc. (1)
Emerald Bioscience, Inc. (3)
Emergent BioSolutions Inc. (1)
Entera Bio Ltd. (2)
ENZON PHARMACEUTICALS, INC. (2)
Equillium, Inc. (1)
EXACT SCIENCES CORP (1)
Exelixis (1)
EXICURE, INC. (8)
FENNEC PHARMACEUTICALS INC. (4)
Fibrocell Science, Inc. (6)
FIVE PRIME THERAPEUTICS INC (1)
Flex Pharma, Inc. (3)
Flexion Therapeutics Inc (1)
Forma Therapeutics Holdings, Inc., (1)
Fortress Biotech, Inc. (2)
Frequency Therapeutics, Inc. (4)
FS Development Corp. (3)
FS Development Corp. II (2)
G1 Therapeutics, Inc. (1)
Gain Therapeutics, Inc. (2)
GALECTIN THERAPEUTICS INC (2)
Galecto Inc. (1)
Galera Therapeutics, Inc. (2)
Gemphire Therapeutics Inc. (5)
Generation Bio Co. (2)
GENOCEA BIOSCIENCES, INC. (1)
Genprex, Inc. (2)
GERON CORP (2)
Gilead Sciences (1)
GLYCOMIMETICS INC (1)
Grail, Inc. (2)
Graphite Bio, Inc. (1)
Gritstone Oncology, Inc. (1)
GTX INC (2)
HALOZYME THERAPEUTICS INC (1)
Health Sciences Acquisitions Corp (2)
HEAT BIOLOGICS, INC. (1)
HERON THERAPEUTICS, INC. (1)
HISTOGENICS CORP (4)
iBio, Inc. (2)
IDEAYA Biosciences, Inc. (1)
IDERA PHARMACEUTICALS, INC. (6)
Imago BioSciences, Inc. (2)
IMMUCELL CORP (1)
IMMUNE PHARMACEUTICALS INC (2)
Immune Therapeutics, Inc. (1)
Immuneering Corp (1)
IMMUNOGEN INC (1)
Immunome Inc. (4)
IMMUNOMEDICS INC (2)
IN8BIO, INC. (1)
Incyte (1)
Inhibrx, Inc. (2)
INOVIO PHARMACEUTICALS, INC. (2)
Inozyme Pharma, Inc. (2)
INSMED Inc (2)
Inspyr Therapeutics, Inc. (1)
Instil Bio, Inc. (1)
INTERCEPT PHARMACEUTICALS, INC. (1)
Invitae Corp (1)
IONIS PHARMACEUTICALS INC (1)
IRONWOOD PHARMACEUTICALS INC (2)
Isoray, Inc. (7)
Kadmon Holdings, Inc. (2)
KalVista Pharmaceuticals, Inc. (5)
Karyopharm Therapeutics Inc. (1)
KBL MERGER CORP. IV (5)
Keros Therapeutics, Inc. (1)
Kezar Life Sciences, Inc. (2)
Kiniksa Pharmaceuticals, Ltd. (1)
Kiromic Biopharma, Inc. (2)
Kronos Bio, Inc. (2)
Kura Oncology, Inc. (3)
LA JOLLA PHARMACEUTICAL CO (3)
LEXICON PHARMACEUTICALS, INC. (1)
LianBio (2)
Ligand Pharmaceuticals Incorporated (4)
LONGEVERON LLC (2)
Lyell Immunopharma, Inc. (2)
Magenta Therapeutics, Inc. (4)
MARIZYME INC (1)
Marker Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (9)
Matinas BioPharma Holdings, Inc. (4)
MAXCYTE, INC. (1)
MEDICINOVA INC (3)
MEI Pharma, Inc. (3)
MeiraGTx Holdings plc (2)
MERRIMACK PHARMACEUTICALS INC (10)
Mersana Therapeutics, Inc. (1)
Merus N.V. (2)
Metacrine, Inc. (1)
Millendo Therapeutics, Inc. (5)
MiMedx Group, Inc. (4)
MIRAGEN THERAPEUTICS, INC. (4)
Mirati Therapeutics, Inc. (5)
Moderna, Inc. (3)
Moleculin Biotech, Inc. (1)
Momenta Pharmaceuticals, Inc. (3)
Monte Rosa Therapeutics, Inc. (1)
Myovant Sciences Ltd. (2)
Myriad Genetics, Inc. (3)
NANOVIRICIDES, INC. (1)
NAVIDEA BIOPHARMACEUTICALS, INC. (3)
NEUROTROPE BIOSCIENCE, INC. (3)
Neurotrope, Inc. (5)
NEWLINK GENETICS CORP (5)
NexImmune, Inc. (1)
Nkarta, Inc. (1)
NTN BUZZTIME INC (8)
Ohr Pharmaceutical Inc (2)
Olema Pharmaceuticals, Inc. (2)
Olivia Ventures, Inc. (1)
Omega Therapeutics, Inc. (3)
OncBioMune Pharmaceuticals, Inc (1)
OncoCyte Corp (4)
ONCOSEC MEDICAL Inc (4)
OPGEN INC (1)
Ophthotech Corp. (2)
Opko Health, Inc. (2)
Orchard Therapeutics plc (1)
Organicell Regenerative Medicine, Inc. (1)
Organogenesis Holdings Inc. (3)
ORGANOVO HOLDINGS, INC. (4)
Outlook Therapeutics, Inc. (3)
Passage BIO, Inc. (5)
PDL BIOPHARMA, INC. (5)
Pfenex Inc. (3)
Phio Pharmaceuticals Corp. (1)
PIERIS PHARMACEUTICALS, INC. (3)
PMV Pharmaceuticals, Inc. (1)
POLARITYTE, INC. (3)
Praxis Precision Medicines, Inc. (1)
PRECISION BIOSCIENCES INC (1)
Prelude Therapeutics Inc (2)
PROGENITY, INC. (1)
Protagonist Therapeutics, Inc (1)
PROTEON THERAPEUTICS INC (5)
PROTEOSTASIS THERAPEUTICS, INC. (8)
Prothena Corp plc (1)
PTC THERAPEUTICS, INC. (1)
Radius Health, Inc. (5)
REGENXBIO Inc. (2)
RenovaCare, Inc. (1)
Repare Therapeutics Inc. (1)
Replimune Group, Inc. (7)
Retrophin, Inc. (1)
REXAHN PHARMACEUTICALS, INC. (3)
RHYTHM PHARMACEUTICALS, INC. (2)
RIGEL PHARMACEUTICALS INC (1)
RITTER PHARMACEUTICALS INC (1)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (2)
Sana Biotechnology, Inc. (1)
SANGAMO THERAPEUTICS, INC (1)
Sarepta Therapeutics, Inc. (7)
Savara Inc (6)
Scholar Rock Holding Corp (2)
SELECTA BIOSCIENCES INC (2)
SELLAS Life Sciences Group, Inc. (3)
Sensei Biotherapeutics, Inc. (1)
SERA PROGNOSTICS, INC. (1)
Seres Therapeutics, Inc. (3)
Sesen Bio, Inc. (2)
Sierra Oncology, Inc. (2)
Social Capital Suvretta Holdings Corp. III (2)
Solid Biosciences Inc. (3)
SOLIGENIX, INC. (2)
Spectrum Pharmaceuticals, Inc. (1)
Spero Therapeutics, Inc. (5)
SPRUCE BIOSCIENCES, INC. (4)
SQZ Biotechnologies Co (3)
Stoke Therapeutics, Inc. (1)
SUNESIS PHARMACEUTICALS INC (1)
Surface Oncology, Inc. (1)
SYNLOGIC, INC. (12)
Synthetic Biologics, Inc. (3)
Syros Pharmaceuticals, Inc. (1)
T2 Biosystems, Inc. (2)
TENAX THERAPEUTICS, INC. (4)
TG THERAPEUTICS, INC. (1)
Tocagen Inc (1)
Transcode Therapeutics, Inc. (2)
Translate Bio, Inc. (1)
TREVENA INC (3)
Trovagene, Inc. (1)
TScan Therapeutics, Inc. (1)
TYME TECHNOLOGIES, INC. (1)
Ultragenyx Pharmaceutical Inc. (1)
uniQure N.V. (3)
Unity Biotechnology, Inc. (1)
Unum Therapeutics Inc. (1)
UroGen Pharma Ltd. (5)
VACCINEX, INC. (1)
Vaxart, Inc. (2)
Vaxcyte, Inc. (1)
Vera Therapeutics, Inc. (2)
VERACYTE, INC. (3)
Verastem, Inc. (1)
Vertex Pharmaceuticals Inc (1)
Verve Therapeutics, Inc. (1)
VICAL INC (5)
Vir Biotechnology, Inc. (1)
VITRO DIAGNOSTICS INC (1)
Vor Biopharma Inc. (1)
Voyager Therapeutics, Inc. (5)
vTv Therapeutics Inc. (1)
WINDTREE THERAPEUTICS INC (4)
Xencor Inc (2)
Xenetic Biosciences, Inc. (2)
Xilio Therapeutics, Inc. (1)
XOMA Corp (1)
Y-mAbs Therapeutics, Inc. (2)
YIELD10 BIOSCIENCE, INC. (1)
ZIOPHARM ONCOLOGY INC (5)
Zymeworks Inc. (2)

Recent Contracts

Employment and Separation Agreement between the Company and Elizabeth L. Williams dated as of December 6, 2024 (IMMUCELL CORP, Filed With SEC on December 9, 2024)
Separation and Release Agreement, dated as of April 10, 2024 (as revised on April 23, 2024, April 26, 2024 and April 29, 2024), by and between Kalaris Therapeutics. Inc. and... (Allovir, Inc., Filed With SEC on December 9, 2024)
Separation and Release Agreement, by and between Armata Pharmaceuticals, Inc. and Mina Pastagia, M.D., dated as of December 2, 2024 (AmpliPhi Biosciences Corp, Filed With SEC on December 4, 2024)
Separation Agreement and Release, by and between Omega Therapeutics, Inc. and Mahesh Karande, effective November 26, 2024 (Omega Therapeutics, Inc., Filed With SEC on November 14, 2024)
Separation Agreement, dated June 27, 2024, between the Company and Matthias Alder (Gain Therapeutics, Inc., Filed With SEC on November 14, 2024)
Separation Agreement, dated July 30, 2024, by and between the Registrant and Kama Hamed (Spero Therapeutics, Inc., Filed With SEC on November 14, 2024)
Separation Agreement by and between the Pieris Pharmaceuticals GmbH and Shane Olwill, Ph.D., dated as of July 23, 2024 (PIERIS PHARMACEUTICALS, INC., Filed With SEC on November 13, 2024)
Separation Agreement, dated as of July 30, 2024, by and between the Registrant and Edwin Rock (GLYCOMIMETICS INC, Filed With SEC on November 13, 2024)
Separation Agreement between Perspective Therapeutics, Inc. and Mark Austin, dated August 26, 2024 (Isoray, Inc., Filed With SEC on November 12, 2024)
Separation and Release Agreement, by and between the Registrant and Timothy Pigot, dated August 15, 2024 (Aerovate Therapeutics, Inc., Filed With SEC on November 12, 2024)
Separation Agreement, by and between the Company and Trishna Goswami, dated as of September 6, 2024 (IN8BIO, INC., Filed With SEC on November 12, 2024)
Amendment to Separation Agreement by and between Synlogic, Inc. and Mary Beth Dooley, dated as of February 17, 2024 (SYNLOGIC, INC., Filed With SEC on November 12, 2024)
Amendment to Separation Agreement by and between Synlogic, Inc. and Antoine Awad, dated as of February 17, 2024 (SYNLOGIC, INC., Filed With SEC on November 12, 2024)
Separation and Release Agreement, dated as of August 4, 2024, by and between MEI Pharma, Inc. and David M. Urso (MEI Pharma, Inc., Filed With SEC on November 12, 2024)
Separation and Release Agreement, dated as of August 3, 2024, by and between MEI Pharma, Inc. and Richard G. Ghalie (MEI Pharma, Inc., Filed With SEC on November 12, 2024)
Separation and Release Agreement, dated August 26, 2024, between Achieve Life Sciences, Inc. and John Bencich (ACHIEVE LIFE SCIENCES, INC., Filed With SEC on November 7, 2024)
Separation Agreement, dated August 9, 2024 by and between the Company and Sébastien Hazard, M.D (Celsion CORP, Filed With SEC on November 7, 2024)
Separation Agreement and Release between the Registrant and Sophia Randolph, M.D., Ph.D (ALX ONCOLOGY HOLDINGS INC, Filed With SEC on November 7, 2024)
Separation Agreement and Release between the registrant and Donna Shiroma dated June 28, 2024 (Avita Therapeutics, Inc., Filed With SEC on November 7, 2024)
Employment Separation Agreement, effective as of September 21, 2024, between the Registrant and Vittal Vasista (REGENXBIO Inc., Filed With SEC on November 6, 2024)
Separation Agreement between the Registrant and Fang Ni, dated October 7, 2024 (Black Diamond Therapeutics, Inc., Filed With SEC on November 5, 2024)
Separation Agreement Release of Claims, dated September 30, 2024, between CareDx, Inc. and Alexander Johnson (CareDx, Inc., Filed With SEC on November 4, 2024)
Separation and Release Agreement, dated October 10, 2024, between Crinetics Pharmaceuticals, Inc. and James Hassard (Crinetics Pharmaceuticals, Inc., Filed With SEC on October 16, 2024)
Separation Agreement and General Release, dated October 5, 2024, by and between the Company and Mark A. Demitrack, MD (TREVENA INC, Filed With SEC on October 10, 2024)
Separation Agreement and General Release, dated October 5, 2024, by and between the Company and Barry Shin (TREVENA INC, Filed With SEC on October 10, 2024)
Separation Agreement and General Release, dated October 5, 2024, by and between the Company and Carrie L. Bourdow (TREVENA INC, Filed With SEC on October 10, 2024)
Separation Agreement between BioXcel Therapeutics, Inc. and Matthew Wiley, dated October 3, 2024 (BioXcel Therapeutics, Inc., Filed With SEC on October 9, 2024)
Separation Agreement between the Company and Don Kim, dated October 7, 2024 (UroGen Pharma Ltd., Filed With SEC on October 9, 2024)
Separation Agreement and Release of Claims, dated September 30, 2024, between CareDx, Inc. and Alexander Johnson (CareDx, Inc., Filed With SEC on October 4, 2024)
Confidential Separation and Release Agreement by and between Armata Pharmaceuticals, Inc. and Richard Rychlik dated as of September 30, 2024 (AmpliPhi Biosciences Corp, Filed With SEC on October 3, 2024)
Separation Agreement, dated September 13, 2024, with Jeffrey L. Wade (LEXICON PHARMACEUTICALS, INC., Filed With SEC on September 16, 2024)
Separation and Release Agreement dated September 5, 2024 and First Amendment to Separation and Release Agreement dated September 5, 2024, by and between Cannbiorex Pharma Ltd.,... (KBL MERGER CORP. IV, Filed With SEC on September 9, 2024)
Separation Agreement by and between the Registrant and T. Andrew Crockett, dated March 6, 2024 (KalVista Pharmaceuticals, Inc., Filed With SEC on September 5, 2024)
Separation Agreement by and between the Company and Jeremy Gowler, dated May 31, 2024 (Adagio Therapeutics, Inc., Filed With SEC on August 14, 2024)
Separation Agreement by and between the Company and David Hering, dated May 3, 2024 (Adagio Therapeutics, Inc., Filed With SEC on August 14, 2024)
Separation Agreement and General Release by Robert A. Beardsley, dated June 4, 2024 (Galera Therapeutics, Inc., Filed With SEC on August 14, 2024)
Separation Agreement dated April 16, 2024 between Brainstorm Cell Therapeutics Inc. and Stacy Lindborg (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on August 14, 2024)
Confidential Separation Agreement and General Release, dated June 19, 2024, between Curtis Lockshin and Xenetic Biosciences, Inc (Xenetic Biosciences, Inc., Filed With SEC on August 13, 2024)
Confidential Separation Agreement and General Release, dated June 19, 2024, between Jeffrey Eisenberg and Xenetic Biosciences, Inc (Xenetic Biosciences, Inc., Filed With SEC on August 13, 2024)
Separation Agreement, effective as of May 31, 2024, by and between the CervoMed Inc. and J. William Tanner, Ph.D (Diffusion Pharmaceuticals Inc., Filed With SEC on August 9, 2024)